1. Others Apoptosis
  2. Insecticide Apoptosis
  3. D-Tetramethrin

D-Tetramethrin is a type I synthetic pyrethroid insecticide and hepatotoxicity inducer. D-Tetramethrin induces oxidative stress in the liver of zebrafish. D-Tetramethrin induces Apoptosis and inflammatory responses. D-Tetramethrin causes severe liver damage in zebrafish. D-Tetramethrin can be used in studies related to hepatotoxicity.

For research use only. We do not sell to patients.

D-Tetramethrin

D-Tetramethrin Chemical Structure

CAS No. : 1166-46-7

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

D-Tetramethrin is a type I synthetic pyrethroid insecticide and hepatotoxicity inducer. D-Tetramethrin induces oxidative stress in the liver of zebrafish. D-Tetramethrin induces Apoptosis and inflammatory responses. D-Tetramethrin causes severe liver damage in zebrafish. D-Tetramethrin can be used in studies related to hepatotoxicity[1].

In Vivo

D-Tetramethrin (0.5-1.5 mg/L) induces dose-dependent hepatotoxicity in zebrafish larvae, with effects including reduced liver volume, yolk absorption disorder, histopathological liver damage, glucose and lipid metabolism disorder, oxidative stress, inflammatory response, and inhibited hepatocyte proliferation[1].
D-Tetramethrin (0.1-0.15 mg/L; 28 days) induces dose-dependent hepatotoxicity in adult zebrafish, with effects including hepatic histopathological damage, lipid and glucose metabolic disorders, and altered activities of metabolic enzymes[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Transgenic Tg(fabp10a: DsRed); wild-type AB (3 days post-fertilization)[1]
Dosage: 0.5 mg/L; 1 mg/L; 1.5 mg/L
Administration: waterborne exposure; daily;
Result: Reduced liver fluorescence area by 10.38% (0.5 mg/L), 7.62% (1 mg/L), and 13.75% (1.5 mg/L) relative to controls.
Increased yolk area by 22.63% (0.5 mg/L), 23.61% (1 mg/L), and 41.32% (1.5 mg/L) relative to controls.
Induced nuclear deformities, loose irregular intercellular gaps, vacuoles, cytoplasmic loss, and nuclear distortion in hepatocytes.
Increased lipid accumulation in a concentration-dependent manner.
Elevated total cholesterol (TC) and total triglycerides (TG) levels significantly across all doses.
Increased alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities significantly relative to controls.
Increased reactive oxygen species (ROS) levels in a concentration-dependent manner.
Elevated catalase (CAT) activity significantly across all doses.
Elevated malondialdehyde (MDA) content significantly across all doses.
Reduced superoxide dismutase (SOD) activity significantly at 1 mg/L and 1.5 mg/L.
Increased expression of apoptosis-related genes (casp-3, casp-6, casp-9, Bax, P53) significantly, while decreased Bcl-2 expression significantly.
Increased Bax/Bcl-2 ratio significantly.
Increased expression of inflammation-related gene TLR4 significantly, while decreased il-10 expression significantly at 1 mg/L and 1.5 mg/L.
Detected no liver-specific apoptosis via TUNEL staining.
Observed significantly fewer proliferating liver cells via PCNA staining.
Reduced expression of cell cycle-promoting genes (ccne1, ccnd1, cdk6) significantly at 1 mg/L and 1.5 mg/L.
Animal Model: wild-type AB[1]
Dosage: 0.1 mg/L; 0.125 mg/L; 0.15 mg/L
Administration: waterborne exposure; daily continuous; 28 days
Result: Induced nuclear deformities, loose irregular intercellular gaps, and vacuoles in hepatocytes.
Increased lipid droplet accumulation in liver tissue in a concentration-dependent manner.
Elevated low-density lipoprotein cholesterol (LDL-C) levels significantly across all doses.
Increased isocitrate dehydrogenase (cytoplasmic, ICDHc) and glucose-6-phosphate dehydrogenase (G6PDH) activities significantly across all doses.
Increased lactate dehydrogenase (LDH) activity significantly at 0.1 mg/L, while reduced it significantly at 0.125 mg/L and 0.15 mg/L.
Reduced glycogen content significantly.
Molecular Weight

331.41

Formula

C19H25NO4

CAS No.
SMILES

C(=C(C)C)[C@@H]1[C@@H](C(OCN2C(=O)C3=C(C2=O)CCCC3)=O)C1(C)C

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
D-Tetramethrin
Cat. No.:
HY-W685358
Quantity:
MCE Japan Authorized Agent: